Dear Sirs,

Hereditary spastic paraplegia (HSP) is a neurodegenerative disorder, characterized by progressive spasticity and muscle weakness of both lower extremities \[[@CR1]\]. Spasticity-related symptoms such as muscle stiffness and gait impairments are common and disabling in HSP \[[@CR2]\]. Moreover, patients experience a substantial burden from both physical and mental fatigue \[[@CR2]\]. Our clinical experience is that physical activity positively impacts on these symptoms, whereas psychological stress may impact negatively. This has, however, not been formally investigated. The (partial) lockdown due to the COVID-19 pandemic has profoundly changed people's normal routine, assumably reducing levels of physical activity and increasing psychological stress \[[@CR3]\], thereby creating an opportunity to explore the influence of these changes on symptom severity in HSP.

We conducted a web-based survey among people with pure HSP \[[@CR2]\] in the Netherlands. An invitation was sent to participants from our previous survey (*n* = 109), which was approved by our regional medical-ethics committee. Participants were asked to rate possible changes in levels of physical activity, psychological stress, and symptom severity on a 5-point Likert scale. They were invited and completed the questionnaire during the fifth week of the partial lockdown in the Netherlands. Descriptive statistics were used to analyze the primary data. Additionally, chi-square tests (or Fisher-exact-tests if appropriate) were used to test whether changes in physical activity and psychological stress were associated with changes in symptom severity (*p* \< 0.05). When both physical activity and psychological stress were associated with a specific change in symptom severity, multivariate logistic forward regression analysis was applied to correct for collinearity of these independent determinants.

Fifty-eight participants returned a completed survey. Their average age was 57 years (range 30--77) and 47% was male. A reduction of physical activities was reported by 74% (33% strong decrease, 41% mild decrease), whereas 19% reported no change and 7% mild increase. An increase in psychological stress was reported by 43% (3% strong increase, 40% mild increase), 50% reported no change, and 7% decrease (2% strong, 5% mild). The majority reported a general increase in symptom severity (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1The impact of the COVID-19 partial lockdown measures on spasticity-related symptoms in people with pure HSP. Participants reported whether the experienced symptom severity increased (mild or strong), decreased (mild or strong) or did not change. Only those participants who experienced a specific symptom (either before or after the lockdown) are included in the figure

Participants with reduced physical activity more often experienced increased muscle stiffness (*p* = 0.001), pain (p = 0.004), physical fatigue \[*χ*^2^(1) = 4.680, *p* = 0.031\], and gait impairments \[*χ*^2^(1) = 5.129, *p* = 0.024\] compared to those with no change or an increase in physical activity (Fig. [2](#Fig2){ref-type="fig"}). The same trend was seen for balance impairments \[*χ*^2^(1) = 3.291, *p* = 0.070\]. Those who reported increased levels of psychological stress more often reported an increase in muscle stiffness \[*χ*^2^(1) = 4.612, *p* = 0.032\], pain \[*χ*^2^(1) = 3.943, *p* = 0.047\], and mental fatigue \[*χ*^2^(1) = 6.234, *p* = 0.013\]. Forward regression analysis of muscle stiffness and pain revealed that only decreased physical activity was independently associated with an increase in muscle stiffness \[*R*^2^ = 0.236 (*p* \< 0.001)\] and pain \[*R*^2^ = 0.193 (*p* = 0.003)\].Fig. 2The impact of physical activity and psychological stress on symptom severity in people with pure HSP. *Y*-axis represents number of people with HSP who experienced the symptom

Six participants were treated with intramuscular botulinum toxin injections to reduce spasticity-related symptoms. During the lockdown, treatment continued in five participants.

The partial lockdown in the Netherlands due to the COVID-19 pandemic resulted in a reduction of physical activity in the majority of participants with HSP, which proved to be associated with increased muscle stiffness, pain, physical fatigue and gait impairments. This result is coherent with findings in other chronic (neurodegenerative) conditions \[[@CR4]\] and underscores the potential impact of physical activity on symptom severity in people with HSP. Future studies may investigate whether the present findings can be extended to other conditions resulting in spastic paraparesis (e.g. multiple sclerosis and primary lateral sclerosis). Future studies may also evaluate the effect of interventions targeting daily physical activity in this population, preferably including objective outcomes, which were lacking in the present study. Another limitation is the lack of comparison between current and previous clinical status, which was not possible due to the lockdown restrictions. An additional limitation is the risk of selection bias, which may have resulted in an overestimation of changes in physical activity, psychological stress, and/or symptom severity. The question remains whether people with HSP are able to return to 'baseline' levels of functioning after release of the lockdown and expected increase in physical activity.
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